WUHAN, China (April 28, 2015) - Wuhan Optoelectronics Forum No. 93 was successfully held in Auditorium A101 at Wuhan National Laboratory for Optoelectronics (WNLO) in the afternoon of April 28.
Cancer has been a leading cause of death since the beginning of human history. Various therapies have been developed, yet cancer remains to be one of the biggest medical challenges for researchers and practitioners. In an attempt to target the root cause of cancer, we developed laser immunotherapy (LIT). LIT aims at eradicating cancers by enlisting the help of the host immune system through a local intervention. It uses the combination of laser phototherapy and immunotherapy to induce tumor-specific immune responses. In our pre-clinical and preliminary clinical studies, LIT is shown to be highly effective against metastatic tumors. The experimental results indicated a systemic, long-term anti-tumor immunological response induced by LIT, using the entire tumor cell as the sources of tumor antigens, based on the principle of in situ autologous whole-cell cancer vaccination. This talk will introduce to the audience the development of LIT and its pre-clinical and preliminary clinical results.
Wei R. Chen currently is an Assistant Dean at the Colleges of Mathematics and Science, and Professor of Biomedical Engineering; he established the Center for Interdisciplinary Biomedical Education and Research and serves as its Director; at the University of Central Oklahoma. He is the Editor-in-Chief for the Journal of X-Ray Science and Technology. His main research interests laser treatment of cancer. Dr. Chen is the co-inventor of the novel cancer treatment method, laser immunotherapy (LIT), using laser irradiation and immunological stimulation. LIT has been used in initial clinical trials for late-stage, metastatic melanoma and breast cancer patients with promising outcomes. Dr. Chen had published more than 120 peer-reviewed articles. He has been awarded eight US patents and several international patents. As principal investigator, Dr. Chen has received more than $4 million for research and education from federal and state agencies, as well as from industrial sponsors. Dr. Chen established in 2006, and since chaired, the international conference "Biophotonics and Immune Responses" at the annual Photonics West Symposium sponsored by SPIE (International Society for Optics and Photonics). Dr. Chen was elected SPIE Fellow in 2007. Dr. Chen was selected as 2008 US Professor of the Year (the highest teaching award in the United States).
